Paclitaxel-Eluting Coronary Stents [3] (multiple letters)

New England Journal of Medicine

Volumn 350, Issue 20, 2004, Pages 2099-2100

  Ajani, Andrew E ^a   Waksman, Ron ^b   Stone, Gregg W ^c   Ellis, Stephen G ^d   Russell, Mary E ^e  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e Boston Scientific   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; PACLITAXEL; DRUG DERIVATIVE; PYRIDINE DERIVATIVE; THIENOPYRIDINE; TICLOPIDINE;

CLINICAL TRIAL; CORONARY STENT; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; HUMAN; LETTER; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RESTENOSIS; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; CORONARY ARTERY OBSTRUCTION; NOTE; STENT;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY RESTENOSIS; CORONARY STENOSIS; HUMANS; PACLITAXEL; PLATELET AGGREGATION INHIBITORS; PYRIDINES; STENTS; THROMBOSIS; TICLOPIDINE;

EID: 2342521353     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200405133502018     Document Type: Letter

References (0)